Publicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (45)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  2. SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression

    Cancers, Vol. 14, Núm. 4

2021

  1. RANK links senescence to stemness in the mammary epithelia, delaying tumor onset but increasing tumor aggressiveness

    Developmental Cell, Vol. 56, Núm. 12, pp. 1727-1741.e7

2020

  1. Author Correction: Identification and characterization of Cardiac Glycosides as senolytic compounds (Nature Communications, (2019), 10, 1, (4731), 10.1038/s41467-019-12888-x)

    Nature Communications

2019

  1. A multifunctional drug nanocarrier for efficient anticancer therapy

    Journal of Controlled Release, Vol. 294, pp. 154-164

  2. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency

    Stem Cell Reports, Vol. 12, Núm. 5, pp. 1099-1112

  3. Identification and characterization of Cardiac Glycosides as senolytic compounds

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Adult Sox2+ stem cell exhaustion in mice results in cellular senescence and premature aging

    Aging Cell, Vol. 17, Núm. 5

  2. Pkd2 deletion during embryo development does not alter mesonephric programmed cell senescence

    International Journal of Developmental Biology, Vol. 62, Núm. 9-10, pp. 637-640

2015

  1. Transcriptional regulation of Sox2 by the retinoblastoma family of pocket proteins

    Oncotarget, Vol. 6, Núm. 5, pp. 2992-3002

2013

  1. Ghrelin requires p53 to stimulate lipid storage in fat and liver

    Endocrinology, Vol. 154, Núm. 10, pp. 3671-3679

  2. XProgrammed cell senescence during mammalian embryonic development

    Cell, Vol. 155, Núm. 5, pp. 1104

2012

  1. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency

    Aging Cell, Vol. 11, Núm. 1, pp. 41-50

  2. Oncogenicity of the developmental transcription factor Sox9

    Cancer Research, Vol. 72, Núm. 5, pp. 1301-1315

  3. P27Kip1 directly represses Sox2 during embryonic stem cell differentiation

    Cell Stem Cell, Vol. 11, Núm. 6, pp. 845-852

2011

  1. Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence

    Cancer Cell, Vol. 19, Núm. 6, pp. 728-739

  2. SIRT1 stabilizes PML promoting its sumoylation

    Cell Death and Differentiation, Vol. 18, Núm. 1, pp. 72-79

2010

  1. Exploring a 'pro-senescence approach for prostate cancer therapy by targeting PTEN

    Future Oncology

  2. Senescence in tumours: Evidence from mice and humans

    Nature Reviews Cancer, Vol. 10, Núm. 1, pp. 51-57